HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launchnews2026-01-28T15:26:09+00:00January 28th, 2026|Endpoints News|
FDA lifts hold on one of two Phase 3 gene editing studies by Intellianews2026-01-27T15:52:33+00:00January 27th, 2026|Endpoints News|
ACIP members depict diverging goals after schedule changenews2026-01-23T18:24:41+00:00January 23rd, 2026|Endpoints News|
J&J praises new FDA guidance to speed development of multiple myeloma drugsnews2026-01-21T18:35:12+00:00January 21st, 2026|Endpoints News|
Government funding bill features PBM reforms, voucher reauthorizationnews2026-01-20T19:14:42+00:00January 20th, 2026|Endpoints News|
Valneva withdraws chikungunya vaccine from USnews2026-01-20T18:37:12+00:00January 20th, 2026|Endpoints News|
Drugmakers without MFN pacts are bracing to make onenews2026-01-16T20:48:34+00:00January 16th, 2026|Endpoints News|
Makary talks FDA’s plans to combat China’s biotech growthnews2026-01-16T19:51:37+00:00January 16th, 2026|Endpoints News|
Trump asks Congress to codify ‘most favored nation’ dealsnews2026-01-15T19:10:11+00:00January 15th, 2026|Endpoints News|
Proprio Reports: 4th FDA Clearance Highlights Growing Shift to 3D Measurement in Spine Carenews2026-01-15T18:19:31+00:00January 15th, 2026|Medical Device News Magazine|
